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ABCD progression post
crosslinking for Keratoconus
Sonali Patel, Dr. Neil Vadhar, Dr. Zeba Syed

Introduction
• Keratoconus à corneal disease
– Cornea thins out and becomes cone shaped

• Most common treatment à Cross Linking
– Riboflavin drops are placed on the patients eyes and allowed to sit
– The treated eye is then exposed to UV light
• increases the degree of interfibrillar collagen cross linking
• Extra strength from cross linking can help stop the progression of keratoconus.

Introduction
• Post-surgical outcomes of cross linking à traditionally
analyzed using an AK (Amsler- Krumeich) system
– Could not account for posterior corneal surface and corneal thickness)

• New ABCD classification was developed
– Takes into account anterior (A) and posterior (B) radius of curvature,
the thinnest corneal pachymetry (C) and the distance for best
corrected vision (D)
– Data collected via Pentamcam

• extra information should help describe the keratoconic cornea
in a much improved manner /allow for more personalized
treatment plans.

Objectives
& Hypothesis
• Research Question
– How do ABCD measurements fluctuate with the changes in visual
acuity post cross linking surgery?

• Hypothesis
– ABCD measurements should all decrease post cross linking surgery

Approach & Results
• A retrospective study was done using 104 patients who
underwent CXL treatment for keratoconus at Wills Eye
between 1/2016 and 6/2019
• previous Lasix surgery was an exclusion criteria
– corneas might show different post-surgical changes

• Measurements were taken using a Pentacam.
– pre-operatively
– post operatively at months 3 and 6
– D value not readily available for all of the patients and thus
was not collected.
– Increases in these measurements à disease progression
– decreases à Disease regression

Approach & Results

Conclusions
• A, B and C à initially progressed post-operatively at 3
months
– B and C values progresses to a much higher degree than A
value
– 6 months post operatively:
• A values regressed past baseline
• B and C values also regressed but not past baseline.

• CXL surgery à improves keratoconus in the anterior
cornea but not as effective in the posterior cornea
• Initial regression in the B and C value ànot a concern
– stabilize later than the A value
– does not mean that the CXL surgery was unsuccessful

Future Directions
• Longer follow up times:
– looking at patient data at 9 or 12 months could
help pinpoint when the posterior chamber and
corneal thickness stabilize in disease progression.

• Increased sample size
– the amount of eyes looked at was relatively small
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